SEPTRIN Side Effects

6888042-8 | Peripheral Sensorimotor Neuropathy
on Jul 23, 2010 Male patient from SPAIN , 36 years of age, was diagnosed with antibiotic prophylaxis, antiviral prophylaxis, immunosuppression, antifungal prophylaxis and was treated with Septrin (View Usage). Patient experienced the following unwanted or unexpected effects: peripheral sensorimotor neuropathy. Septrin dosage: . During the same period patient was treated with ACYCLOVIR (1.6g Per Day) (View Acyclovir Review and Acyclovir Label ), CYCLOPHOSPHAMIDE (200mg Per Day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VORICONAZOLE (800mg Per Day) (View Voriconazole Review and Voriconazole Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

6740224-1 | Upper Gastrointestinal Haemorrhage
Patient was taking Septrin (View Usage). Patient had the following side effects: upper gastrointestinal haemorrhage on May 14, 2010 from SPAIN Additional patient health information: Female patient , 87 years of age, was diagnosed with respiratory tract infection, atrial fibrillation (What is atrial fibrillation?), depression (What is depression?), prophylaxis and. Septrin dosage: . During the same period patient was treated with DIGOXIN (.75mg Weekly) (View Digoxin Review and Digoxin Label ), SERTRALINE HCL (50mg Per Day) (View Sertraline Hcl Review and Sertraline Hcl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PLAVIX (75mg Per Day) (View Plavix Review and Plavix Label ).

6713656-5 | Upper Gastrointestinal Haemorrhage
Adverse event was reported on Apr 27, 2010 by a Female patient taking Septrin (View Usage) (Dosage: ) was diagnosed with respiratory tract infection, atrial fibrillation (What is atrial fibrillation?), depression (What is depression?) and. Location: SPAIN , 87 years of age, After Septrin was administered, patient had the following side effects: upper gastrointestinal haemorrhage. During the same period patient was treated with DIGOXIN (.75mg Weekly) (View Digoxin Review and Digoxin Label ), SERTRALINE HCL (50mg Per Day) (View Sertraline Hcl Review and Sertraline Hcl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PLAVIX (75mg Per Day) (View Plavix Review and Plavix Label ).

6428475-7 | Dermatitis Bullous, Dermatitis Exfoliative, Eye Disorder, Hypoxia, Live Birth, Purulent Discharge, Stevens-johnson Syndrome, Tachycardia
on Oct 27, 2009 Female patient from NIGERIA , 27 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Septrin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, dermatitis exfoliative, eye disorder, hypoxia, live birth, purulent discharge, stevens-johnson syndrome, tachycardia. Septrin dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.


6202059-8 | Toxic Epidermal Necrolysis
on May 14, 2009 Male patient from SPAIN , 49 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Septrin (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Septrin dosage: . During the same period patient was treated with PREDNISONE (20mg Per Day) (View Prednisone Review and Prednisone Label ), ACYCLOVIR SODIUM (800mg Per Day) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), OMEPRAZOL (20mg Per Day) (View Omeprazol Review and Omeprazol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CELLCEPT (1500mg Three Times Per Day) (View Cellcept Review and Cellcept Label ), INSULIN INSULATARD NPH NORDISK (View Insulin Insulatard Nph Nordisk Review and Insulin Insulatard Nph Nordisk Label ), INSULIN NOVO ACTRAPID (View Insulin Novo Actrapid Review and Insulin Novo Actrapid Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

4894872-4 | Deep Vein Thrombosis, Graft Versus Host Disease, Haemangioma, Impaired Healing, Lesion Excision, Scleroderma, Skin Ulcer
Patient was taking Septrin (View Usage). After Septrin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), graft versus host disease, haemangioma, impaired healing, lesion excision, scleroderma (What is scleroderma?), skin ulcer on Jan 20, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 34 years of age, was diagnosed with bone marrow transplant (What is bone marrow transplant?) and. Septrin dosage: . During the same period patient was treated with PENICILLIN (View Penicillin Review and Penicillin Label ), MYCOPHENOLATE MOFETIL (1 G, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

4777923-7 | Immunosuppression, Toxic Epidermal Necrolysis
Adverse event was reported on Sep 12, 2005 by a Female patient taking Septrin (View Usage) (Dosage: 120 Mg Bid Po) was diagnosed with acute myeloid leukaemia and. Location: UNITED KINGDOM , weighting 26.24 lb, Patient experienced the following unwanted or unexpected effects: immunosuppression, toxic epidermal necrolysis. During the same period patient was treated with CYTARABINE (1100 Mg Daily Iv) (View Cytarabine Review and Cytarabine Label ), FLUDARABINE PHOSPHATE (17 Mg Daily Iv) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CODEINE (View Codeine Review and Codeine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ).

4753703-3 | Toxic Epidermal Necrolysis
on Jul 22, 2005 Female patient from UNITED KINGDOM , weighting 26.24 lb, was diagnosed with acute myeloid leukaemia and was treated with Septrin (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Septrin dosage: 120 Mg Bid Po. During the same period patient was treated with CYTARABINE (1100 Mg Daily Iv) (View Cytarabine Review and Cytarabine Label ), FLUDARABINE PHOSPHATE (17 Mg Daily Iv) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CODEINE (View Codeine Review and Codeine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ).